X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1301) 1301
Publication (260) 260
Book Review (39) 39
Newspaper Article (33) 33
Book Chapter (25) 25
Book / eBook (10) 10
Conference Proceeding (8) 8
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (891) 891
animals (781) 781
humans (766) 766
immunology (709) 709
mice (454) 454
immunotherapy (435) 435
t cells (366) 366
dendritic cells (363) 363
cancer (341) 341
lymphocytes (308) 308
in-vivo (248) 248
oncology (239) 239
t cell receptors (234) 234
immune system (224) 224
article (212) 212
antigens (210) 210
cytokines (210) 210
regulatory t-cells (192) 192
lymphocytes t (187) 187
tumors (186) 186
t-lymphocytes - immunology (178) 178
signal transduction (176) 176
female (174) 174
inflammation (174) 174
mice, inbred c57bl (172) 172
neoplasms - immunology (172) 172
research (163) 163
care and treatment (160) 160
immune response (157) 157
activation (153) 153
expression (149) 149
cell biology (144) 144
review (143) 143
health aspects (140) 140
t-lymphocytes, regulatory - immunology (139) 139
ligands (136) 136
neoplasms - therapy (132) 132
analysis (131) 131
immunotherapy - methods (129) 129
immunity (128) 128
dendritic cells - immunology (125) 125
apoptosis (121) 121
cutting edge (121) 121
medicine, research & experimental (121) 121
proteins (120) 120
t-cells (115) 115
mice, knockout (113) 113
receptor (111) 111
gene expression (108) 108
toll-like receptors (108) 108
cd4-positive t-lymphocytes - immunology (104) 104
cd8-positive t-lymphocytes - immunology (104) 104
antibodies, monoclonal - therapeutic use (101) 101
lymphocyte activation (99) 99
nf-kappa-b (99) 99
biochemistry & molecular biology (98) 98
melanoma (96) 96
tumor necrosis factor (94) 94
monoclonal antibodies (93) 93
tumor-necrosis-factor (93) 93
asthma (90) 90
male (90) 90
rodents (89) 89
chemical and pharmacologic phenomena (88) 88
signal transduction - immunology (88) 88
cytotoxicity (86) 86
ox40 (85) 85
antibodies (83) 83
autoimmunity (83) 83
responses (83) 83
antitumor immunity (82) 82
vaccines (82) 82
cells, cultured (81) 81
costimulation (81) 81
medical research (81) 81
medicine (81) 81
mice, inbred balb c (81) 81
t-lymphocyte subsets - immunology (81) 81
flow cytometry (80) 80
immune-responses (79) 79
research article (79) 79
lymphocyte activation - immunology (77) 77
multidisciplinary sciences (76) 76
allergy (75) 75
physiological aspects (75) 75
cytokines - metabolism (74) 74
cell proliferation (72) 72
pharmacology & pharmacy (72) 72
disease models, animal (71) 71
allergy and immunology (70) 70
cancer therapies (69) 69
hemic and immune systems (68) 68
cell differentiation (67) 67
drug therapy (67) 67
genetic aspects (67) 67
hematology (67) 67
biology (66) 66
cd4 antigen (66) 66
receptors, ox40 - immunology (66) 66
science (66) 66
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Immunological Reviews, ISSN 0105-2896, 11/2011, Volume 244, Issue 1, pp. 218 - 231
OX40 (CD134) is a tumor necrosis factor (TNF) receptor expressed primarily on activated CD4+ and CD8+ T cells and transmits a potent costimulatory signal when... 
immunotherapies | tumor immunity | costimulation | T cells | Tumor immunity | Costimulation | Immunotherapies | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | T-CELL SURVIVAL | OX40/OX40 LIGAND INTERACTION | EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS | IMMUNOLOGY | VERSUS-HOST-DISEASE | GROWTH-FACTOR RECEPTOR | IN-VIVO | LYMPHOKINE MESSENGER-RNA | ANTITUMOR IMMUNITY | MONOCLONAL-ANTIBODIES | Receptors, OX40 - agonists | Receptors, OX40 - genetics | Humans | Antibodies, Monoclonal - therapeutic use | Receptors, OX40 - immunology | CD4-Positive T-Lymphocytes - immunology | Signal Transduction - immunology | Inflammation - drug therapy | Gene Expression - immunology | Immune Tolerance - drug effects | Immunity, Innate - drug effects | Translational Medical Research | Immunologic Factors - administration & dosage | Rats | Clinical Trials as Topic | Inflammation - immunology | Lymphocytes, Tumor-Infiltrating - drug effects | Haplorhini | Mice, Knockout | Neoplasms - drug therapy | Animals | Signal Transduction - drug effects | Antibodies, Monoclonal - administration & dosage | Lymphocyte Activation - drug effects | Neoplasms - immunology | CD8-Positive T-Lymphocytes - drug effects | Cell Proliferation - drug effects | Mice | CD8-Positive T-Lymphocytes - immunology | Neoplasms - pathology | CD4-Positive T-Lymphocytes - drug effects | Immunologic Factors - therapeutic use | Lymphocytes, Tumor-Infiltrating - immunology | Receptors, OX40 - antagonists & inhibitors | Animal experimentation | Care and treatment | Analysis | Immunotherapy | Oncology, Experimental | Research | Tumors | Cancer
Journal Article
FRONTIERS IN ONCOLOGY, ISSN 2234-943X, 02/2015, Volume 5
Recent studies have highlighted the therapeutic efficacy of immunotherapy, a class of cancer treatments that utilize the patient's own immune system to destroy... 
OX40 | PD-1 BLOCKADE | EFFECTOR FUNCTION | REGULATORY T | CANCER-IMMUNOTHERAPY | co-stimulation | IMMUNOSTIMULATORY MONOCLONAL-ANTIBODIES | TUMOR-INFILTRATING LYMPHOCYTES | THERAPEUTIC ANTITUMOR IMMUNITY | ONCOLOGY | RECEPTOR IN-VIVO | immunotherapy | T-CELL-ACTIVATION | COSTIMULATORY MOLECULE | CTLA-4 | cancer | PD-1
Journal Article
The Journal of Immunology, ISSN 0022-1767, 10/2009, Volume 183, Issue 8, pp. 4853 - 4857
Journal Article
Cancer Research, ISSN 0008-5472, 07/2008, Volume 68, Issue 13, pp. 5206 - 5215
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 07/2017, Volume 23, Issue 13, pp. 3416 - 3427
Purpose: To generate and characterize a murine GITR ligand fusion protein (mGITRL-FP) designed to maximize valency and the potential to agonize the GITR... 
EFFECTOR | RESPONSES | ACTIVATION | FC-GAMMA RECEPTORS | ONCOLOGY | IN-VIVO | REGULATORY T-CELLS | CANCER-IMMUNOTHERAPY | SUPPRESSION | TNF | TUMOR-IMMUNITY | Tumor Necrosis Factors - agonists | Tumor Necrosis Factors - genetics | Humans | Melanoma, Experimental - therapy | Membrane Glycoproteins - agonists | Glucocorticoid-Induced TNFR-Related Protein - administration & dosage | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Oncogene Proteins, Fusion - administration & dosage | CTLA-4 Antigen - immunology | Tumor Necrosis Factors - immunology | B7-H1 Antigen - immunology | Oncogene Proteins, Fusion - immunology | Animals | B7-H1 Antigen - antagonists & inhibitors | Melanoma, Experimental - genetics | Melanoma, Experimental - immunology | CD8-Positive T-Lymphocytes - drug effects | Glucocorticoid-Induced TNFR-Related Protein - immunology | Mice | Membrane Glycoproteins - immunology | Programmed Cell Death 1 Receptor - immunology | CD8-Positive T-Lymphocytes - immunology | CTLA-4 Antigen - antagonists & inhibitors | Disease Models, Animal | Cell proliferation | Animal models | PD-1 protein | CD8 antigen | Antibodies | Antagonists | Lymphocytes T | Immunity | Anticancer properties | Proteins | CTLA-4 protein | Lymphocytes | Immunotherapy | Fusion protein | Valency | CD4 antigen | Ox40L protein | Immune checkpoint | Experimental design | Tumor necrosis factor | PD-L1 protein | Antitumor activity | Ligands | Cancer | Tumors
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 04/2018, Volume 117, Issue 5, pp. 840 - 844
Background and Objectives OX40, a membrane‐bound molecule of the tumor‐necrosis‐factor‐receptor superfamily, is a critical costimulatory receptor during the... 
neoplasm | stomach | receptor OX40 (CD134) | immunotherapy | SURGERY | LIGAND INTERACTION | OX-40 | TNF SUPERFAMILY | TUMOR-INFILTRATING LYMPHOCYTES | ONCOLOGY | ASTHMA | ENGAGEMENT | GENERATION | EXPRESSION | T-CELLS | CD134 | Monoclonal antibodies | Immune response | T cells | Stomach cancer | Analysis | Cancer
Journal Article
Journal of Autoimmunity, ISSN 0896-8411, 2011, Volume 37, Issue 4, pp. 342 - 351
Journal Article
Journal Article
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 12/2009, Volume 58, Issue 12, pp. 1941 - 1947
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2014, Volume 9, Issue 2, p. e89350
The co-inhibitory receptor Programmed Death-1 (PD-1) curtails immune responses and prevent autoimmunity, however, tumors exploit this pathway to escape from... 
SURVIVAL | ENHANCES ANTITUMOR IMMUNITY | IMMUNOGENICITY | ANTI-PD-1 ANTIBODY | IMMUNOTHERAPY | INFILTRATING LYMPHOCYTES | MULTIDISCIPLINARY SCIENCES | IN-VIVO | MOUSE MODEL | REGULATORY T-CELLS | PERIPHERAL-BLOOD LYMPHOCYTES | T-Lymphocyte Subsets - immunology | Receptors, OX40 - agonists | Ovarian Neoplasms - pathology | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - administration & dosage | Ovarian Neoplasms - mortality | T-Lymphocytes, Cytotoxic - drug effects | Receptors, OX40 - metabolism | Myeloid Cells - immunology | T-Lymphocyte Subsets - drug effects | Immunotherapy | Female | Myeloid Cells - drug effects | Antineoplastic Agents - pharmacology | Ovarian Neoplasms - metabolism | Cytotoxicity, Immunologic - drug effects | Ovarian Neoplasms - drug therapy | Disease Models, Animal | T-Lymphocytes, Cytotoxic - immunology | Tumor Microenvironment - drug effects | Antigens, Neoplasm - immunology | Antibodies, Monoclonal - pharmacology | Programmed Cell Death 1 Receptor - metabolism | Epitopes, T-Lymphocyte | Tumor Burden | Tumor Microenvironment - immunology | Animals | Antibodies, Monoclonal - administration & dosage | T-Lymphocyte Subsets - metabolism | Cell Line, Tumor | Mice | Ovarian Neoplasms - immunology | Autoimmunity | T cells | Immunity | Analysis | Ovarian cancer | Cytolytic activity | Animal models | Ovarian carcinoma | CD8 antigen | Clinical trials | Antibodies | Effector cells | Lymphocytes T | Cancer therapies | Anticancer properties | Inoculation | Cell activation | Lymphocytes | Foxp3 protein | Immune system | Spleen | Medical research | Antigens | Immunoglobulins | CD11b antigen | Immunological memory | Immune response | Immunostimulation | Cell survival | Cytokines | Gynecology | Obstetrics | CD4 antigen | Polymerase chain reaction | Immunosuppression | Chemotherapy | Hospitals | Immunogenicity | γ-Interferon | Monoclonal antibodies | Ligands | Antitumor activity | Interferon | Combinatorial analysis | Tumors | Peritoneum | Apoptosis | Cancer
Journal Article